Successful treatment of young childhood standard-risk hepatoblastoma with cisplatin monotherapy using a central review system.

Isamu SaekiKohmei IdaSho KuriharaKenichiro WatanabeMakiko MoriTomoro HishikiAkiko YokoiJunya FujimuraShohei HondaYuki NogamiTomoko IeharaTakuro KazamaMasahiro SekiguchiNorihiko KitagawaRisa MatsumuraMotonari NomuraYohei YamadaRyo HanakiHide KanedaYuichi TakamaTakeshi InoueYukichi TanakaOsamu MiyazakiHiroki NagaseTetsuya TakimotoKenichi YoshimuraEiso Hiyama

Published in: Pediatric blood & cancer (2024)

CDDP monotherapy regimen is feasible in young patients with localized HB, as classified by a central review.

Keyphrases

combination therapy
open label
middle aged
randomized controlled trial
study protocol